Towards Healthcare

Weight Management Companies, Recent Strategic Partnerships, Operational Enhancements, Strategic Resource Allocation, Intellectual Property (IP) Portfolio Management, Financial Performance Evaluation

Date: November 2024

Weight Management Market Companies

The global weight management market size is calculated at USD 163.13 billion in 2024 and is expected to be worth USD 362.1 billion by 2034, expanding at a CAGR of 8.3% from 2024 to 2034.

Weight Management Market Companies

The weight management companies are:

  • Herbalife Ltd.
  • Weight Watchers International
  • Jenny Craig
  • Medifast Inc.
  • Atkins Nutritionals, Inc.
  • Nestlé
  • Kellanova
  • Johnson & Johnson Services, Inc.
  • Olympus Corporation
  • Medifast Inc.
  • Nutrisystem Ltd.

Competitive Landscape

In the weight management market, big companies are known worldwide, and smaller local ones and new startups are trying to get more customers and develop new ideas. The big companies have been around for a long time and are famous for their weight loss programs and products. They spend a lot of money on advertising and have many customers. But now, there are also smaller companies focusing on health and wellness. They use technology like apps and gadgets to help people track their food and exercise and give them advice.

Some companies even make medicine that doctors can prescribe to help people lose weight. With the internet, many new small businesses have also popped up. They might sell special foods or offer unique services like delivering meals to your home or giving advice online. And don't forget about traditional ways of losing weight, like acupuncture or herbal remedies – they're also popular!

Latest Announcements by Industry Leaders

Pascal Soriot, CEO of AstraZeneca, commented that the future marketplace will center less on treating obesity and focus more on sustained weight management. AstraZeneca finished a $185 million deal to reenter into GLP-1 frenzy. He said that GLP-1 oral small molecules that are part of a combination treatment to limit muscle loss will be the future, instead of injectable options. He predicted that GLP-1 will be mainly preferred by people expecting 5-10% of weight loss for cosmetic reasons, to prevent future metabolic issues, or both.

Recent Developments

  • In November 2024, Allurion Technologies launched AllurionMeds to give patients GLP-1 medications for weight loss combined with its AI-enabled Coach Iris platform. The company aims to advance long-term weight maintenance through virtual access to dieticians and a connected smart scale to measure weight, muscle, and bone mass.
  • In 2022, the WHO launched the “WHO Acceleration Plan to Stop Obesity” initiative to prevent and manage obesity globally.

If you have any questions, please feel free to contact us at sales@towardshealthcare.com